|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
KEEGO HARBOR, Mich., Nov. 07, 2017-- ZIVO Bioscience, Inc., a Michigan-based biotech firm, invites shareholders, analysts and partners to its annual shareholder meeting on Wednesday, November 8, 2017, ...
KEEGO HARBOR, Mich., Sept. 19, 2017-- ZIVO Bioscience, Inc. a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products derived from proprietary algal strains, announces ...
NEW YORK, NY / ACCESSWIRE / May 4, 2017 / JGR Capital Partners, a leading equity research firm, has announced it has initiated coverage on Zivo Bioscience (OTCQB: ZIVO) with a base case financial valuation ...
NEW YORK, NY / ACCESSWIRE / February 14, 2017 / Consumers continue to vote with their dollars away from sugary drinks and towards those that provide a health benefit. Actions at large beverage companies ...
ZIVO Bioscience, Inc. , a company dedicated to the development and commercialization of nutritional compounds and bioactive molecules derived from its proprietary algal strains, and NutriQuest LLC, an ...